Literature DB >> 9760989

Ribonuclease 4, an evolutionarily highly conserved member of the superfamily.

J Hofsteenge1, A Vicentini, O Zelenko.   

Abstract

The structural and enzymatic properties of RNase 4 are reviewed. This RNase shows a much higher interspecies similarity (approximately 90%) than the other members of the RNase A superfamily. The enzyme is ubiquitous, with the highest amounts present in liver and lung. Its unique uridine specificity results from alterations in and around the pyrimidine-binding site. In particular, the shortened C-terminus and the side chains of Phe-42, Asp-80 and Arg-101 appear to be involved. RNase 4 binds tightly to the intracellular RNase inhibitor, with a Kd of 4 x 10(-15) M.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9760989     DOI: 10.1007/s000180050209

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  13 in total

Review 1.  Ribonuclease inhibitor: structure and function.

Authors:  Kimberly A Dickson; Marcia C Haigis; Ronald T Raines
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

2.  Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress.

Authors:  Shuping Li; Jinghao Sheng; Jamie K Hu; Wenhao Yu; Hiroko Kishikawa; Miaofen G Hu; Kaori Shima; David Wu; Zhengping Xu; Winnie Xin; Katherine B Sims; John E Landers; Robert H Brown; Guo-fu Hu
Journal:  Angiogenesis       Date:  2012-11-10       Impact factor: 9.596

3.  Mechanism and Function of Angiogenin in Prostate Cancer.

Authors:  Nil Vanli; H U Guo-Fu
Journal:  Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao       Date:  2015-12-24

Review 4.  Functional roles of the human ribonuclease A superfamily in RNA metabolism and membrane receptor biology.

Authors:  Heng-Huan Lee; Ying-Nai Wang; Mien-Chie Hung
Journal:  Mol Aspects Med       Date:  2019-03-25

5.  Ribonuclease 4 is associated with aggressiveness and progression of prostate cancer.

Authors:  Nil Vanli; Jinghao Sheng; Shuping Li; Zhengping Xu; Guo-Fu Hu
Journal:  Commun Biol       Date:  2022-06-25

Review 6.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

7.  Sequence-specific backbone (1)H, (13)C, and (15)N resonance assignments of human ribonuclease 4.

Authors:  Donald Gagné; Nicolas Doucet
Journal:  Biomol NMR Assign       Date:  2014-07-17       Impact factor: 0.746

Review 8.  Three decades of research on angiogenin: a review and perspective.

Authors:  Jinghao Sheng; Zhengping Xu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-12-23       Impact factor: 3.848

9.  Expression and function of human ribonuclease 4 in the kidney and urinary tract.

Authors:  Kristin Bender; Laura L Schwartz; Ariel Cohen; Claudia Mosquera Vasquez; Matthew J Murtha; Tad Eichler; Jason P Thomas; Ashley Jackson; John David Spencer
Journal:  Am J Physiol Renal Physiol       Date:  2021-04-05

10.  The first crystal structure of human RNase 6 reveals a novel substrate-binding and cleavage site arrangement.

Authors:  Guillem Prats-Ejarque; Javier Arranz-Trullén; Jose A Blanco; David Pulido; M Victòria Nogués; Mohammed Moussaoui; Ester Boix
Journal:  Biochem J       Date:  2016-03-24       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.